ESMO Breast Cancer 2022
Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer - ScienceDirect
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
36:1%3C1::aid-cncr2820360102%3E3.0.co;2-4.fp.png "The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) - Fisher - 1975 - Cancer - Wiley Online Library")
The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) - Fisher - 1975 - Cancer - Wiley Online Library
Should Pfizer's Ibrance give up early-stage breast cancer drug market? < Pharma < Article - KBR
Risk for breast cancer recurrence as determined by Adjuvant! Online and... | Download Scientific Diagram
Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer | Breast Cancer Research | Full Text
Cancers | Free Full-Text | Breast Cancer during Pregnancy—Current Paradigms, Paths to Explore
Herceptin® (trastuzumab) Dosing in HER2+ Adjuvant Breast Cancer
Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients - Bossuyt - 2020 - The Breast Journal - Wiley Online Library
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial - The Lancet Oncology
adjuvant online
Addressing overtreatment in breast cancer - Katz - 2013 - Cancer - Wiley Online Library
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer | NEJM
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE | npj Breast Cancer
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
A calculated choice | Cancer World Archive
Prognostic data based on population-based analysis with Adjuvant!... | Download Scientific Diagram
Assessment of Risk Recurrence: Adjuvant Online, OncotypeDx & Mammaprint
What is adjuvant therapy for breast cancer? | MD Anderson Cancer Center
